PROCEPT BioRobotics Reports Q3 Revenue of $98.3 Million, EPS of -$0.46 Misses Estimates
Company Reaffirms Full-Year 2026 Revenue Guidance of $390 Million to $410 Million Despite Wider Net Loss Related Stocks: PRCT ,
Company Reaffirms Full-Year 2026 Revenue Guidance of $390 Million to $410 Million Despite Wider Net Loss Related Stocks: PRCT ,